Epithelial membrane protein (EMP1) overexpression has been reported to enhance RSL3-induced iron sagging in HNSCC cells by promoting gefitinib resistance through targeting the MAPK pathway [38]. Here, EMP1 is linked to head and neck squamous cell carcinoma.